Revance Therapeutics GAAP EPS of -$0.88 beats by $0.03, revenue of $28.37M beats by $0.6M (NASDAQ:RVNC) – Seeking Alpha

0
48
Revance Therapeutics GAAP EPS of -$0.88 beats by $0.03, revenue of $28.37M beats by $0.6M (NASDAQ:RVNC) - Seeking Alpha



Revance Therapeutics GAAP EPS of -$0.88 beats by $0.03, revenue of $28.37M beats by $0.6M (NASDAQ:RVNC)  Seeking Alpha



Source link